Stay updated on PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial page.

Latest updates to the PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial page
- Check6 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2 on the page.SummaryDifference0.1%

- Check13 days agoChange DetectedPublications section now clarifies that listed publications are automatically filled from PubMed, and a revision note shows Revision: v3.3.1, replacing the previous wording (Revision: v3.2.0).SummaryDifference0.1%

- Check21 days agoChange DetectedThe government funding status notice was removed from the page. It previously warned that updates may not be up to date and directed users to opm.gov for updates.SummaryDifference0.4%

- Check35 days agoChange DetectedNew metadata entries were added indicating the last known status, the investigator Yanhong Deng from Sun Yat-sen University, the date by 2023-10, and verification status.SummaryDifference0.8%

- Check63 days agoChange DetectedUpdate includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment with potential service impact; previous version reference (v3.1.0) was removed.SummaryDifference4%

- Check71 days agoChange DetectedUpgrade to version v3.1.0 with a new identifier and contact (dengyanh@mail.sysu.edu.cn), replacing the previous v3.0.2 version.SummaryDifference0.1%

Stay in the know with updates to PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 Antibody and COX Inhibitor in Colorectal Cancer Clinical Trial page.